Sip Wijchers: Is It Time to Use Ultrasound for Every AF Ablation Access?
Sip Wijchers, Cardiologist-electrophysiologist at Erasmus MC, shared a post on LinkedIn:
”We’ve optimized anticoagulation in AF ablation. But what about the puncture?
Vascular access complications remain the most common adverse event in AF ablation. And yet, many labs still rely on landmark-based femoral venous access.
The ULYSSES trial challenges that habit.
In 986 patients undergoing AF/LA tachycardia ablation, ultrasound-guided access reduced clinically relevant vascular complications from 3.3% to 0.6% (RR 0.19, p=0.002) (Schaack et al., 2026).
But the real signal may be elsewhere:
- Arterial puncture: 16% – 2%
- Failed venous access: 8.2% – 0.2%
- No increase in procedure time
This is not about marginal gains.
This is about predictability and safety at the very first step of the procedure.
And importantly, this aligns with decades of data across vascular access:
Ultrasound improves success and reduces complications in central lines, subclavian access, and femoral arterial puncture (Teja et al., 2024; Zawadka et al., 2023; Strauss et al., 2025).
So the real question is no longer does it help?
It’s:
Can we still justify not using it?
- Yes, the absolute risk reduction is modest.
- Yes, the trial was stopped early.
But when a low-cost, widely available tool reduces the most frequent complication of a high-volume procedure… the bar for “routine use” should be low.
Should ultrasound-guided femoral venous access now be the default in AF ablation?
Or is palpation still acceptable in experienced hands?
Curious how this is implemented in your lab.”
Stay updated with Hemostasis Today.
-
Apr 21, 2026, 16:32Sarah Walbolt։ Have You Ever Wondered What Actually Happens to Your Donated Blood?
-
Apr 21, 2026, 16:08Piotr Czempik: Hidden Platelet Dysfunction in Sepsis and Septic Shock
-
Apr 21, 2026, 16:04Akshat Jain: Personalized Hemophilia Care in the Era of Novel Therapies
-
Apr 21, 2026, 16:03Abdelaziz Fahem։ Novo Nordisk Reports Positive Phase 3 Results for Etavopivat
-
Apr 21, 2026, 16:01Augustina Isioma Ikusemoro: ABO Discrepancies in Transfusion Practice
-
Apr 21, 2026, 15:56Haroon A Mann: Focusing on Inequities in Haemophilia Care in Low-Resource Settings at WHC 2026
-
Apr 21, 2026, 15:56Mohammed Murad Hossain: Final Presentation and Certificate Award Ceremony
-
Apr 21, 2026, 15:51Chokri Ben Lamine: High-Yield Differentiation of Eosinophilic Disorders
-
Apr 21, 2026, 15:48David Palma: From Clinical Trial to Your Clinic – IJROBP